The tariff classification of a Tablo Console, Tablo Cartridge, and TabloCart from Mexico
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the TabloCart in both configurations will be 9402.90.0020, HTSUS, which provides for “[m]edical, surgical, dental or veterinary furniture … : [o]ther: [o]ther.” The rate of duty will be free.
Ruling text
In your letter dated January 18, 2025, you requested a tariff classification ruling on behalf of Outset Medical Inc. Supplemental information was summitted by email, dated January 30, 2025. The products under consideration are a “Tablo Hemodialysis System Console,” a “Tablo Cartridge,” and a “TabloCart.” The Console and the Cartridge constitute the Tablo Hemodialysis System. The Cart is an optional component of the system.
The Tablo Hemodialysis System performs a critical medical function by removing waste, toxins, and excess fluids from the blood, replicating the natural filtration performed by healthy kidneys. It is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. The system is also indicated for use in the home.
You claim that while the Tablo Hemodialysis System Console could be used for acute or transient renal failure, the vast majority (approximately 90 percent) of dialysis patients that utilize the Tablo console suffer from end-stage renal disease (chronic renal failure).
You state “[t]he primary difference between a machine designed for acute kidney failure (acute kidney injury, AKI) and one designed for end-stage renal disease (ESRD) lies in their purpose, usability, treatment frequency, and patient condition.” “Although the same dialysis machines can be used for both acute kidney injury (AKI) and end-stage renal disease (ESRD), they are ultimately designed with chronic kidney failure patients in mind.” You explain that standard hemodialysis machines are built for long-term, repetitive use to manage ESRD patients.
While these machines can be adapted to treat AKI patients in certain settings, the primary focus of their design is to support sustained, ongoing treatment rather than temporary kidney recovery. “Conversely, continuous renal replacement therapy (CRRT) machines are specifically optimized for critically ill patients with AKI.” “Despite some overlap in machine usage, the distinction in their intended purpose remains crucial in tailoring treatment to the patient's condition.
Outset Medical’s Tablo machine, [which is the subject of this ruling], is not cleared for continuous renal replacement therapy (CRRT).” The Tablo Console is a single module consisting of multiple fluidic systems that perform the activities of a water purification system and a conventional dialysis delivery system and has four lockable wheels.
The Tablo Cartridge consists of arterial and venous bloodlines, a saline line, an infusion line, infusion ports, clamps, a saline spike, a venous transducer protector, a venous pressure transducer interface elbow, a venous drip chamber, an arterial pressure pod, a blood return saline router, and a T-connector connected in a specially designed plastic housing. The cartridge is a single use, disposable cartridge that is inserted onto the front panel of the Console for each dialysis treatment.
It is an integral piece of the dialysis process, necessary to complete hemodialysis, and compatible only with the Tablo Hemodialysis System. The TabloCart is available in two configurations.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N345258).